250 related articles for article (PubMed ID: 15105121)
21. Methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus epidermidis infections in the cornea.
Sotozono C; Inagaki K; Fujita A; Koizumi N; Sano Y; Inatomi T; Kinoshita S
Cornea; 2002 Oct; 21(7 Suppl):S94-101. PubMed ID: 12484707
[TBL] [Abstract][Full Text] [Related]
22. Treatment of methicillin-resistant Staphylococcus aureus in neonatal mice: lysostaphin versus vancomycin.
Placencia FX; Kong L; Weisman LE
Pediatr Res; 2009 Apr; 65(4):420-4. PubMed ID: 19127212
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Oguz H; Ozbilge H; Oguz E; Gurkan T
Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
[TBL] [Abstract][Full Text] [Related]
24. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus keratitis in rabbits.
Tas T; Kucukbayrak A; Hakyemez IN; Mengeloglu FZ; Simavli H; Ozyalvacli G; Erdurmus M
Cornea; 2013 Jul; 32(7):1052-7. PubMed ID: 23665649
[TBL] [Abstract][Full Text] [Related]
25. Ex vivo efficacy of gemifloxacin in experimental keratitis induced by methicillin-resistant Staphylococcus aureus.
Marino A; Blanco AR; Ginestra G; Nostro A; Bisignano G
Int J Antimicrob Agents; 2016 Oct; 48(4):395-400. PubMed ID: 27554440
[TBL] [Abstract][Full Text] [Related]
26. In vivo activity of ceftobiprole in murine skin infections due to Staphylococcus aureus and Pseudomonas aeruginosa.
Fernandez J; Hilliard JJ; Abbanat D; Zhang W; Melton JL; Santoro CM; Flamm RK; Bush K
Antimicrob Agents Chemother; 2010 Jan; 54(1):116-25. PubMed ID: 19884364
[TBL] [Abstract][Full Text] [Related]
27. The inhibitory effect of vancomycin ointment on the manifestation of MRSA keratitis in rabbits.
Eguchi H; Shiota H; Oguro S; Kasama T
J Infect Chemother; 2009 Oct; 15(5):279-83. PubMed ID: 19856064
[TBL] [Abstract][Full Text] [Related]
28. Pseudomonas aeruginosa LasA protease and corneal infections.
Alionte LG; Cannon BM; White CD; Caballero AR; O'Callaghan RJ; Hobden JA
Curr Eye Res; 2001 Apr; 22(4):266-71. PubMed ID: 11462165
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of mupirocin and polymyxin B in experimental Staphylococcus aureus, Pseudomonas aeruginosa, and Serratia marcescens keratitis.
Moreau JM; Conerly LL; Hume EB; Dajcs JJ; Girgis DO; Cannon BM; Thibodeaux BA; Stroman DW; O'Callaghan RJ
Cornea; 2002 Nov; 21(8):807-11. PubMed ID: 12410042
[TBL] [Abstract][Full Text] [Related]
30. Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococcus and Pseudomonas keratitis.
Lauffenburger MD; Cohen KL
Cornea; 1993 Nov; 12(6):517-21. PubMed ID: 8261784
[TBL] [Abstract][Full Text] [Related]
31. Clarithromycin for experimental Staphylococcus aureus keratitis.
Hume EB; Moreau JM; Conerly LL; Cannon BM; Dajcs JJ; Hill JM; O'Callaghan RJ
Curr Eye Res; 1999 May; 18(5):358-62. PubMed ID: 10372997
[TBL] [Abstract][Full Text] [Related]
32. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.
Marangon FB; Miller D; Muallem MS; Romano AC; Alfonso EC
Am J Ophthalmol; 2004 Mar; 137(3):453-8. PubMed ID: 15013867
[TBL] [Abstract][Full Text] [Related]
33. Methicillin-resistant Staphylococcus aureus keratitis in the rabbit: therapy with ciprofloxacin, vancomycin and cefazolin.
Callegan MC; Hill JM; Insler MS; Hobden JA; O'Callaghan RJ
Curr Eye Res; 1992 Nov; 11(11):1111-9. PubMed ID: 1483341
[TBL] [Abstract][Full Text] [Related]
34. The bactericidal effect of lysostaphin coupled with liposomal vancomycin as a dual combating system applied directly on methicillin-resistant
Hajiahmadi F; Alikhani MY; Shariatifar H; Arabestani MR; Ahmadvand D
Int J Nanomedicine; 2019; 14():5943-5955. PubMed ID: 31447553
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of besifloxacin in an early treatment model of methicillin-resistant Staphylococcus aureus keratitis.
Sanders ME; Moore QC; Norcross EW; Shafiee A; Marquart ME
J Ocul Pharmacol Ther; 2010 Apr; 26(2):193-8. PubMed ID: 20334537
[TBL] [Abstract][Full Text] [Related]
36. Topical Vancomycin 5% Is More Efficacious Than 2.5% and 1.25% for Reducing Viable Methicillin-Resistant Staphylococcus aureus in Infectious Keratitis.
Romanowski EG; Romanowski JE; Shanks RMQ; Yates KA; Mammen A; Dhaliwal DK; Jhanji V; Kowalski RP
Cornea; 2020 Feb; 39(2):250-253. PubMed ID: 31658169
[TBL] [Abstract][Full Text] [Related]
37. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
38. The effectiveness of tobramycin and Ocuflox in a prophylaxis model of Staphylococcus keratitis.
Dajcs JJ; Moreau JM; Stroman DW; Schlech BA; Ke TL; Thibodeaux BA; Girgis DO; Caballero AR; O'Callaghan RJ
Curr Eye Res; 2001 Jul; 23(1):60-3. PubMed ID: 11821987
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis.
Sanders ME; Norcross EW; Moore QC; Shafiee A; Marquart ME
Cornea; 2009 Oct; 28(9):1055-60. PubMed ID: 19724203
[TBL] [Abstract][Full Text] [Related]
40. Staphylococcus aureus keratitis: a review of hospital cases.
Ong SJ; Huang YC; Tan HY; Ma DH; Lin HC; Yeh LK; Chen PY; Chen HC; Chuang CC; Chang CJ; Hsiao CH
PLoS One; 2013; 8(11):e80119. PubMed ID: 24244625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
